Pancreatic Cancer Research

ResearcherKyushu UniversityNo recent work listed

Makoto Kawamoto

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5488-7933; OpenAlex author ID A5072862484. Sources: OpenAlex.

Their work

Papers
10
Trials
0
Grants
0
Labs led
0
Collaborators
30
Papers, trials and grants by year

2016: 3 papers · 2017: 1 paper · 2018: none · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: 2 papers · 2023: 1 paper

Papers 10

  1. C4orf47 contributes to the dormancy of pancreatic cancer under hypoxic conditions. Co-author DOI 10.7150/jca.78993↗
  2. Endoplasmic stress-inducing variants in CPB1 and CPA1 and risk of pancreatic cancer: A case-control study and meta-analysis. Co-author DOI 10.1002/ijc.33883↗
  3. Endoplasmic stress-inducing variants in carboxyl ester lipase and pancreatic cancer risk. Co-author DOI 10.1016/j.pan.2022.08.004↗
  4. Laparoscopic distal pancreatectomy for intraductal papillary mucinous neoplasm-associated pancreatic cancer: A case report. Co-author DOI 10.1016/j.ijscr.2021.106376↗
  5. Patched 1-interacting Peptide Represses Fibrosis in Pancreatic Cancer to Augment the Effectiveness of Immunotherapy. Co-author DOI 10.1097/cji.0000000000000305↗
  6. FAM115C could be a novel tumor suppressor associated with prolonged survival in pancreatic cancer patients. Co-author DOI 10.7150/jca.38399↗
  7. Liprin-α4 as a Possible New Therapeutic Target for Pancreatic Cancer. Co-author DOI 10.21873/anticanres.12122↗
  8. Hypoxia but not normoxia promotes Smoothened transcription through upregulation of RBPJ and Mastermind-like 3 in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2015.11.012↗
  9. Hypoxic Conditions Promote Gemcitabine Sensitivity in a Pancreatic Cancer Stem Cell Line. Co-author PMID 26851020↗
  10. Protein-bound Polysaccharide-K Inhibits Hedgehog Signaling Through Down-regulation of MAML3 and RBPJ Transcription Under Hypoxia, Suppressing the Malignant Phe… Co-author PMID 27466498↗

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hideya Onishi · 7 shared papers, 2016–2023 · strength 0.63
  2. Akira Imaizumi · 6 shared papers, 2016–2023 · strength 0.53
  3. Yasuhiro Oyama · 4 shared papers, 2016–2020 · strength 0.33
  4. Alison P. Klein · 2 shared papers, 2022 · strength 0.28
  5. Michael Goggins · 2 shared papers, 2022 · strength 0.28
  6. Nicholas Jason Roberts · 2 shared papers, 2022 · strength 0.28
  7. Akio Yamasaki · 4 shared papers, 2016–2017 · strength 0.28
  8. Yoshinao Oda · 2 shared papers, 2020–2023 · strength 0.25
  9. Masafumi Nakamura · 2 shared papers, 2020–2023 · strength 0.25
  10. Yoshihiro Miyasaka · 2 shared papers, 2020–2021 · strength 0.21
  11. Takashi Morisaki · 2 shared papers, 2016–2020 · strength 0.16
  12. Shinjiro Nagao · 1 shared paper, 2023 · strength 0.15
  13. Jin Peng He · 1 shared paper, 2022 · strength 0.15
  14. Marcia Irene Canto · 1 shared paper, 2022 · strength 0.15
  15. Takeichi Yoshida · 1 shared paper, 2022 · strength 0.15
  16. Richard Andrew Burkhart · 1 shared paper, 2022 · strength 0.15
  17. Koji Tamura · 1 shared paper, 2022 · strength 0.15
  18. Mitsuo Katano · 2 shared papers, 2016 · strength 0.14
  19. Shiro Kohi · 1 shared paper, 2022 · strength 0.13
  20. Ki Byung Song · 1 shared paper, 2022 · strength 0.13
  21. Toshiya Abe · 1 shared paper, 2022 · strength 0.13
  22. Ralph H. Hruban · 1 shared paper, 2022 · strength 0.13
  23. Daniel A. Laheru · 1 shared paper, 2022 · strength 0.13
  24. Masato Watanabe · 1 shared paper, 2021 · strength 0.11
  25. Hiroki Kaida · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.